Actively Recruiting
Josef Ressel Centre Perinatal Programming
Led by Moenie van der Kleyn · Updated on 2025-03-17
100
Participants Needed
1
Research Sites
488 weeks
Total Duration
On this page
Sponsors
M
Moenie van der Kleyn
Lead Sponsor
C
Christian Doppler Forschungsgesellschaft
Collaborating Sponsor
AI-Summary
What this Trial Is About
Background: Metabolic imprinting through early childhood nutrition seems to play an important role in the aetiology of obesity. Overweight at age two and later in life is associated with excessive weight gain as early as three months of age. Breastfeeding in the first year of life appears to be protective against obesity development. Objective: of the "Josef Ressel Centre for Early Life Metabolic Programming of Dispositions of Obesity" is to identify maternal and infant predictors of metabolic risk of obesity. The main considerations of modifiable factors are early infant nutrition, 24-hours-drinking-volume, the velocity of infant weight gain, in relation to infant fat mass and fat free mass, to biomarker and to the nutritional status of the mother. A second focus is put on maternal feeding style, infant eating behaviour and the identification of satiety cues. Multi-Study design: a monocentric prospective longitudinal cohort of 100 healthy, non-obese, non-smoking pregnant mothers and their term, normal birthweight, singleton babies. Mothers and exclusively breastfed versus exclusively formula fed children (at 16 weeks) will be examined at 36 weeks of pregnancy, 4 - 8 - 12 and 16 weeks of life, follow-up at 1 and 2 years of life. Methods: four weighing protocols between 4th and 16th week of life, feeding diary, anthropometric data measurement of mother and child, child fat mass index by air displacement plethysmograph. Macronutrient and energy content of the breast milk will be analysed by MIRIS™. Well-defined biomarkers of oxidative stress and inflammation, lipid profile, adipokines, insulin, as well as micro- und macronutrients will be analysed as meaningful indicators regarding the development of obesity and/or the metabolic syndrome in newborns. Samples, such as plasma, urine, saliva, and stool of the mothers and children will be examined with High Performance Liquid Chromatography, High Performance Gas Chromatography, Mass Spectrometry, Enzyme-Linked Immunosorbent Assay (ELISA) and more. Also questionnaires for the evaluation of the maternal milk feeding style are used as well as the Baby and Child Eating and Behaviour Questionnaire at 16 weeks, 1 and 2 years. A semi-automatic recognition of infants' satiety cues during feeding will be performed. The recording environment includes video cameras and microphones, a pulse oximeter, etc. All signals are synchronously recorded with the aid of the hardware and software infrastructure.
CONDITIONS
Official Title
Josef Ressel Centre Perinatal Programming
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnancy or mother in puerperium
- Delivery of baby at 37+0 to 41+6 gestational age
- Legal age (18 years old), age limit 50 years
- Written consent of test person after having been informed
- BMI 18.5 kg/m8 to < 30 kg/m8
- Negative result of oral glucose tolerance test during pregnancy
- Birth weight of baby 2.5-4.5 kg
- Non-smoker since knowledge of pregnancy
- Very good knowledge of German language and Caucasian
- Exclusive breastfeeding or exclusive formula feeding at 4th week of life
You will not qualify if you...
- Birth before 37+0 week of pregnancy or after 41+6 week of pregnancy
- Multiple pregnancy
- Children with serious congenital malformations of nervous system, mouth, throat, neck, circulation system, respiratory tract, gastrointestinal tract, urogenital tract, or chromosomal aberrations
- Diseases or hospitalization or intensive medical care of child during neonatal period
- Hereditary metabolic diseases of child including disorders of fat, amino acid, or carbohydrate metabolism
- Drug (tobacco) abuse
- Mental illnesses treated with medication
- Metabolic or autoimmune diseases of mother
- Complications at birth such as blood loss over 1000 ml or eclampsia
- Pre-conceptional diabetes (type 1 or 2)
- Celiac disease and/or wheat protein allergy of mother
- Breast surgery and/or hypomastia
- Mixed feeding at 4th week of life
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
FH Joanneum, university of applied sciences
Graz, Styria, Austria, 8020
Actively Recruiting
Research Team
M
Moenie D van der Kleyn, MPH
CONTACT
E
Erwin Zinser, Prof Dr.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here